Rapid assessment tool for Haemophilus influenzae type b disease in developing countries

43Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

Haemophilus influenzae type b (Hib) still causes a substantial number of deaths among children in developing countries, despite the availability of effective conjugate vaccines. A major obstacle in developing a Hib vaccine has been limited awareness about the impact of Hib disease. A tool was developed to estimate the national rates of Hib meningitis and pneumonia by assessing retrospective local data over 7 to 10 days. Data from 11 countries in Africa, the Middle East, and Asia were studied and showed rates of Hib meningitis from >50 cases per 100,000 children >5 years in Ghana and Uganda to <15 per 100,000 in Iran, Jordan, and Uzbekistan. Results were affected by the quality of available data. The Hib rapid assessment tool can be useful to countries that desire a timely assessment of Hib disease rates.

Cite

CITATION STYLE

APA

Feikin, D. R., Nelson, C. B., Watt, J. P., Mohsni, E., Wenger, J. D., & Levine, O. S. (2004). Rapid assessment tool for Haemophilus influenzae type b disease in developing countries. Emerging Infectious Diseases, 10(7), 1270–1276. https://doi.org/10.3201/eid1007.030737

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free